Effect of RVAD Cannulation Length on Right Ventricular Thrombosis Risk: An In Silico Investigation
Annals of Biomedical Engineering · 2024
DOI: 10.1007/s10439-024-03474-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Biomedical Engineering, 2024. Verfasst von Kar Ying Thum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiorespiratory Engineering and Technology Laboratory, Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Austr…. Hauptthemen laut MEDLINE: Thrombosis, Computer Simulation, Heart Ventricles, Models, Cardiovascular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, National Heart Foundation of Australia, Monash Institute of Medical Engineering, Monash University.
Abstract (Originalsprache)
Left ventricular assist devices (LVADs) have been used off-label as long-term support of the right heart due to the lack of a clinically approved durable right VAD (RVAD). Whilst various techniques to reduce RVAD inflow cannula protrusion have been described, the implication of the protrusion length on right heart blood flow and subsequent risk of thrombosis remains poorly understood. This study investigates the influence of RVAD diaphragmatic cannulation length on right ventricular thrombosis risk using a patient-specific right ventricle in silico model validated with particle image velocimetry. Four cannulation lengths (5, 10, 15 and 25 mm) were evaluated in a one-way fluid–structure interaction simulation with boundary conditions generated from a lumped parameter model, simulating a biventricular supported condition. Simulation results demonstrated that the 25-mm cannulation length exhibited a lower thrombosis risk compared to 5-, 10- and 15-mm cannulation lengths due to improved flow energy distribution (25.2%, 24.4% and 17.8% increased), reduced stagnation volume (72%, 68% and 49% reduction), better washout rate (13.0%, 11.6% and 9.1% faster) and lower blood residence time (6% reduction). In the simulated scenario, our findings suggest that a longer RVAD diaphragmatic cannulation length may be beneficial in lowering thrombosis risk; however, further clinical studies are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiorespiratory Engineering and Technology Laboratory, Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia. karying.thum@monash.edu.
- Cardiorespiratory Engineering and Technology Laboratory, Department of Mechanical and Aerospace Engineering, Monash University, Melbourne, VIC, Australia.
- School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.
- Department of Cardiology, Alfred Hospital, Melbourne, VIC, Australia.
- Department of Cardiothoracic Surgery and Transplantation, Alfred Hospital and Monash University, Melbourne, VIC, Australia.
Förderung
- National Health and Medical Research Council
- National Heart Foundation of Australia
- Monash Institute of Medical Engineering, Monash University
- Monash University
Zitieren
APA
Thum, K. Y., Liao, S., Šeman, M., Khamooshi, M., Carberry, J., McGiffin, D., & Gregory, S. D. (2024). Effect of RVAD Cannulation Length on Right Ventricular Thrombosis Risk: An In Silico Investigation. Annals of Biomedical Engineering. https://doi.org/10.1007/s10439-024-03474-4
Vancouver
Thum KY, Liao S, Šeman M, Khamooshi M, Carberry J, McGiffin D, et al. Effect of RVAD Cannulation Length on Right Ventricular Thrombosis Risk: An In Silico Investigation. Annals of Biomedical Engineering. 2024. doi:10.1007/s10439-024-03474-4
BibTeX
@article{Thum2024,
author = {Thum, Kar Ying and Liao, Sam and Šeman, Michael and Khamooshi, Mehrdad and Carberry, Josie and McGiffin, David and Gregory, Shaun D},
title = {Effect of RVAD Cannulation Length on Right Ventricular Thrombosis Risk: An In Silico Investigation},
journal = {Annals of Biomedical Engineering},
year = {2024},
doi = {10.1007/s10439-024-03474-4}
}
EUVIMED